fashion -WSS

fashion

author：explore 2025-09-29 20:51:51 - browse：4

Illustration of a hospital with stacks of dollar bills on top – private equity coverage from STAT — Adobe

Private equity firms are rapidly buying their way into the U.S. health care system, and as they do, new research finds they tend to increase costs and may also harm quality.

A new BMJ systematic review rounded up 55 studies on the effects of private equity buyouts in health care globally to flesh out an overarching conclusion. The team of researchers found that private equity ownership generally means higher costs for patients, insurance companies, and government programs. The effects on quality were mixed, with more evidence showing that such financial investors degrade quality.

“This is really the first widespread snapshot of what the impacts of all these developments are,” said Alexander Borsa, a study author and doctoral candidate at Columbia University.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Solving academic medical centers' existential crisis

entertainment

WSS

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Air quality improving but still lags in Black, Hispanic communities

How to bring more disabled researchers into academia

How to bring more disabled researchers into academia

It's time to retire 'poor historian' from clinicians' vocabularies

knowledge

fashion

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Alkermes shareholders re

CDC marks new Covid

Wildfire smoke exposes gaps in outdoor worker protections

Data integrity in scientific journals requires "effort" by publishers, institutions

Duchenne breakthrough therapy leaves behind pioneering families

NVIDIA and Google execs on the future of AI and drug discovery

Heart attack and stroke risk calculators need revising

Data integrity in scientific journals requires "effort" by publishers, institutions

entertainment

Case highlights the risks of experimental stem cell therapy

Sen. Paul opposes bill to ban Chinese biotechs

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Glen Campbell's doctor discusses his public struggle with Alzheimer's

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

The problem with charging patients to message their doctors

focus

entertainment

focus

hotspot